A Qualitative Study of Physicians' Perspectives on Non-Cancer Hospice-Palliative Care in Korea: Focus on AIDS, COPD and Liver Cirrhosis.
10.14475/kjhpc.2017.20.3.177
- Author:
Jinyoung SHIN
1
;
Seok Joon YOON
;
Sun Hyun KIM
;
Eon Sook LEE
;
Su Jin KOH
;
Jeanno PARK
Author Information
1. Department of Family Medicine, Konkuk University School of Medicine, Seoul, Korea. sunhyun@yahoo.com, leejeny@paik.ac.kr
- Publication Type:Original Article
- Keywords:
Hospices;
Palliative care;
Delivery of health care;
Qualitative research;
Acquired immunodeficiency syndrome;
Chronic obstructive pulmonary disease;
Liver cirrhosis
- MeSH:
Acquired Immunodeficiency Syndrome;
Delivery of Health Care;
Dyspnea;
Education;
Hospices;
Humans;
Korea*;
Liver Cirrhosis*;
Liver Transplantation;
Liver*;
Medical Staff;
Oxygen;
Palliative Care;
Pulmonary Disease, Chronic Obstructive*;
Qualitative Research;
Specialization
- From:Korean Journal of Hospice and Palliative Care
2017;20(3):177-187
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: From August 2017, hospice-palliative care (HPC) will be provided to patients with acquired immunodeficiency syndrome (AIDS), chronic obstructive pulmonary disease (COPD), and liver cirrhosis in Korea. To contribute to building a non-cancer (NC) hospice-palliative care model, NC specialists were interviewed regarding the goals, details, and provision methods of the model. METHODS: Four physicians specializing in HPC of cancer patients formulated a semi-structured interview with questions extracted from literature review of 85 articles on NC HPC. Eleven NC disease specialists were interviewed, and their answers were analyzed according to the qualitative content analysis process. RESULTS: The interviewees said as follows: It is difficult to define endstage NC patients. HPC for cancer patients and that for NC patients share similar goals and content. However, emphasis should be placed on alleviating other physical symptoms and emotional care rather than pain control. Timing of the care provision should be when patients are diagnosed as “end stage”. Special issues should be considered for each NC disease (e.g., use of anti-retroviral drugs for AIDS patients, oxygen supply for COPD patients suffering from dyspnea, liver transplantation for patients with liver cirrhosis) and education should be provided to healthcare professionals. NC patients tend to negatively perceive HPC, and the government's financial assistance is insufficient. CONCLUSION: It is necessary to define end-stage NC patients through in-depth discussion to minimize issues that will likely accompany the expansion of care recipients. This requires cooperation between medical staff caring for NC patients and HPC givers for cancer patients.
